Skip to content
★ Sign in to follow
EO

Edward O. Hunter

International Stem Cell Corp
Total declarations
21
Company
1
▲ Purchases (20 ops.)
€16k
▼ Sales (0 ops.)
—

Latest filing published 31 Dec 2008 for International Stem Cell CORP.

Insider track record

Disclosed buys
20
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
20
Positive at T+90
50%
Median T+90
+1.4%

Based on 20 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Edward O. Hunter: trading record in brief

Edward O. Hunter discloses dealings in International Stem Cell Corp to SEC (Form 4). The record holds 21 filings, for trades running from 28 March 2008 to 29 December 2008.

The open-market record is one-sided, with 20 purchases worth €16k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant.

In size, the median ticket on the buying side is €773. For 20 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 50% of cases, with a median move of +1.4%. These figures describe past trades and do not predict future prices.

Most recently, on 31 December 2008, the filings show a share grant in International Stem Cell Corp. The clock since the last published purchase (9 December 2008) now reads 6,544 days. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Edward O. Hunter

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total

21 of 21 declarations